نتایج جستجو برای: ezetimibe

تعداد نتایج: 1477  

2017
Frans Stellaard Dieter Lütjohann

The cholesterol balance procedure allows the calculation of cholesterol synthesis based on the assumption that loss of endogenous cholesterol via fecal excretion and bile acid synthesis is compensated by de novo synthesis. Under ezetimibe therapy hepatic cholesterol is diminished which can be compensated by hepatic de novo synthesis and hepatic extraction of plasma cholesterol. The plasma latho...

Journal: :Journal of the American College of Cardiology 2008
Anouk van der Graaf Cynthia Cuffie-Jackson Maud N Vissers Mieke D Trip Claude Gagné Genming Shi Enrico Veltri Hans J Avis John J P Kastelein

OBJECTIVES The study evaluated the efficacy and safety of long-term coadministration of ezetimibe and simvastatin in adolescents with heterozygous familial hypercholesterolemia (HeFH). BACKGROUND Aggressive intervention to achieve lipid goals for adolescents with HeFH is recommended to reduce risk of premature cardiovascular disease. METHODS In a multicenter, randomized, double-blind, place...

Journal: :Journal of the American College of Cardiology 2007
Michael Piorkowski Sabine Fischer Caroline Stellbaum Markus Jaster Peter Martus Andreas J Morguet Heinz-Peter Schultheiss Ursula Rauch

OBJECTIVES We sought to test the platelet inhibitory and anti-inflammatory effects of a higher statin dosage compared with combined treatment with ezetimibe plus a low statin dose. BACKGROUND Reducing the level of low-density lipoprotein cholesterol (LDL-C) with statins induces important pleiotropic effects such as platelet inhibition. An insufficient LDL-C reduction often is treated with eze...

2015
Rohit Loomba Claude B Sirlin Brandon Ang Ricki Bettencourt Rashmi Jain Joanie Salotti Linda Soaft Jonathan Hooker Yuko Kono Archana Bhatt Laura Hernandez Phirum Nguyen Mazen Noureddin William Haufe Catherine Hooker Meng Yin Richard Ehman Grace Y Lin Mark A Valasek David A Brenner Lisa Richards

UNLABELLED Ezetimibe inhibits intestinal cholesterol absorption and lowers low-density lipoprotein cholesterol. Uncontrolled studies have suggested that it reduces liver fat as estimated by ultrasound in nonalcoholic steatohepatitis (NASH). Therefore, we aimed to examine the efficacy of ezetimibe versus placebo in reducing liver fat by the magnetic resonance imaging-derived proton density-fat f...

2014
Weibin Qian Junichi Hasegawa Satoshi Tsuno Yusuke Endo Akiko Matsuda Norimasa Miura

BACKGROUND Bofutsushosan is a well known Kampo, traditional Japanese medicine, based on ancient Chinese medicine mainly used in the treatment of hypercholesterolemia in Japan. We selected two Kampo formulas, Boiogito and Keishibukuryogan mainly used in the treatment of hypercholesterolemia in China to compare with Bofutsushosan and cholesterol absorption inhibitor ezetimibe. METHODS Hyperchol...

Journal: :pharmaceutical and biomedical research 0
hossein danafar zanjan pharmaceutical nanotechnology research center, zanjan university of medical sciences, zanjan, iran

ezetimide belongs to a class of lipid lowering compounds that selectively inhibits intestinal absorption of cholesterol and related phytosterols. the purpose of this study is to establish a reliable and quick method for the assignment of ezetimibe in tablets form by high performance liquid chromatography with ultraviolet detection (hplc-uv). a rapid and sensitive hplc method has been developed ...

2013
Anju Prasad Pratyay Pratim Datta Ritesh Roy Chaitali Pattanayak Parbaty Panda

INTRODUCTION Coronary heart disease and hyperlipidemia is a global problem in today's world. A large number of people suffer from hypertension, atherosclerosis and all these has strong association with the hyperlipidemia. There are many drugs for the treatment of hyperlipidemia, but statins are most commonly used. But, with high dose of statins, the side effect is also there which restricts its...

Journal: :Circulation. Cardiovascular quality and outcomes 2014
Lingyun Lu Harlan M Krumholz Jack V Tu Joseph S Ross Dennis T Ko Cynthia A Jackevicius

BACKGROUND Ezetimibe use has steadily increased in Canada during the past decade even in the absence of evidence demonstrating a beneficial effect on clinical outcomes. Among the 4 most populated provinces in Canada, there is a gradient in the restrictiveness of ezetimibe in public-funded formularies (most to least strict: British Columbia, Alberta, Quebec, and Ontario). The effect of formulary...

Journal: :Current atherosclerosis reports 2008
Anne B Rossebø Terje R Pedersen Kurt Boman Philippe Brudi John B Chambers Kenneth Egstrup Eva Gerdts Christa Gohlke-Bärwolf Ingar Holme Y Antero Kesäniemi William Malbecq Christoph A Nienaber Simon Ray Terje Skjaerpe Kristian Wachtell Ronnie Willenheimer

BACKGROUND Hyperlipidemia has been suggested as a risk factor for stenosis of the aortic valve, but lipid-lowering studies have had conflicting results. METHODS We conducted a randomized, double-blind trial involving 1873 patients with mild-to-moderate, asymptomatic aortic stenosis. The patients received either 40 mg of simvastatin plus 10 mg of ezetimibe or placebo daily. The primary outcome...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید